Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel SCD inhibitors discovered by Daiichi Sankyo

March 17, 2009

Janssen Pharmaceutica claims novel cannabinoid modulators

March 16, 2009

Metabolex patents novel glucose-dependent insulinotropic receptor agonists

March 16, 2009

Novel MC4 receptor agonists prepared and tested at Santhera

March 16, 2009

FDA accepts for review Endo's complete response submission to NDA for Nebido

March 16, 2009

Novel activators of glucokinase developed by Metabasis Therapeutics

March 13, 2009

Uloric now available for hyperuricemia in patients with gout

March 13, 2009

InteKrin completes enrollment in phase IIb study of INT-131 in type 2 diabetes

March 13, 2009

TrialNet centers begin Diamyd vaccine studies for recent-onset type 1 diabetes

March 12, 2009

WAY-207024 is a novel orally active antagonist of GnRH receptor

March 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...